Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sturm, R. A.
Right arrow Articles by Herlyn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sturm, R. A.
Right arrow Articles by Herlyn, M.
[Cancer Research 62, 226-232, January 1, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Osteonectin/SPARC Induction by Ectopic ß3 Integrin in Human Radial Growth Phase Primary Melanoma Cells1

Richard A. Sturm2, Kapaeth Satyamoorthy, Freidegund Meier, Brooke B. Gardiner, Darren J. Smit, Bhavesh Vaidya and Meenhard Herlyn

The Wistar Institute, Philadelphia, Pennsylvania 19104 [R. A. S., K. S., B. V., M. H.]; Centre for Functional and Applied Genomics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia [R. A. S., B. B. G., D. J. S.]; and Department of Dermatology, University of Tübingen, Tübingen, Germany 72076 [F. M.]

Expression of the ß3 integrin subunit in melanoma in situ has been found to correlate with tumor thickness, the ability to invade and metastasize, and poor prognosis. Transition from the radial growth phase (RGP) to the vertical growth phase (VGP) is a critical step in melanoma progression and survival and is distinguished by the expression of ß3 integrin. The molecular pathways that operate in melanoma cells associated with invasion and metastasis were examined by ectopic induction of the ß3 integrin subunit in RGP SBcl2 and WM1552C melanoma cells, which converts these cells to a VGP phenotype. We used cDNA representational difference analysis subtractive hybridization between ß3-positive and -negative melanoma cells to assess gene expression profile changes accompanying RGP to VGP transition. Fourteen fragments from known genes including osteonectin (also known as SPARC and BM-40) were identified after three rounds of representational difference analysis. Induction of osteonectin was confirmed by Northern and Western blot analysis and immunohistochemistry and correlated in organotypic cultures with the ß3-induced progression from RGP to VGP melanoma. Expression of osteonectin was also associated with reduced adhesion to vitronectin, but not to fibronectin. Osteonectin expression was not blocked when melanoma cells were cultured with anti-{alpha}vß3 LM609 mAb, mitogen-activated protein kinase, or protein kinase C inhibitors, indicating that other signaling pathway(s) operate through {alpha}vß3 integrin during conversion from RGP to VGP.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
N. Said, I. Najwer, and K. Motamed
Secreted Protein Acidic and Rich in Cysteine (SPARC) Inhibits Integrin-Mediated Adhesion and Growth Factor-Dependent Survival Signaling in Ovarian Cancer
Am. J. Pathol., March 1, 2007; 170(3): 1054 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Robert, C. Gaggioli, O. Bailet, C. Chavey, P. Abbe, E. Aberdam, E. Sabatie, A. Cano, A. Garcia de Herreros, R. Ballotti, et al.
SPARC Represses E-Cadherin and Induces Mesenchymal Transition during Melanoma Development.
Cancer Res., August 1, 2006; 66(15): 7516 - 7523.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
W. Bao and S. Stromblad
Integrin {alpha}v-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen
J. Cell Biol., November 22, 2004; 167(4): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. Perlis and M. Herlyn
Recent Advances in Melanoma Biology
Oncologist, April 1, 2004; 9(2): 182 - 187.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. J. Pereira, T. Meyer, S. E. Docherty, H. H. Reid, J. Marshall, E. W. Thompson, J. Rossjohn, and J. T. Price
Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with {alpha}v{beta}3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth1
Cancer Res., February 1, 2004; 64(3): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Ordi, M. Creus, L. Quinto, R. Casamitjana, A. Cardesa, and J. Balasch
Within-Subject Between-Cycle Variability of Histological Dating, {alpha}v{beta}3 Integrin Expression, and Pinopod Formation in the Human Endometrium
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2119 - 2125.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, F. Carmona, A. Cardesa, J. A. Vanrell, and J. Balasch
The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study
Hum. Reprod., April 1, 2003; 18(4): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Creus, J. Ordi, F. Fabregues, R. Casamitjana, B. Ferrer, E. Coll, J. A. Vanrell, and J. Balasch
{alpha}v{beta}3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women
Hum. Reprod., September 1, 2002; 17(9): 2279 - 2286.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.